Zymeworks BC Inc. (ZYME) NASDAQ
$9.12 (0.26) (-2.77%)
Market Cap: $644.83M
As of 05/17/24 04:00 PM EDT. Market closed.
Zymeworks BC Inc. (ZYME)
NASDAQ
$9.12
(0.26) (-2.77%)
Market Cap: $644.83M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company’s novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
335
Address
540-1385 West 8Th Avenue, British Columbia, Vancouver, V6H 3V9.
PRICE CHART FOR ZYMEWORKS BC INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.34
Previous Close
$9.38
Days Range
$9.05 - $9.42
52 week range
$6.02 - $13.14
Volume
307,548
Avg. Volume (30 days)
734,219
Market Cap
$644.83M
Dividend Yield
-
P/E
(2.72)
Shares Outstanding
70,704,890
Open
$9.34
Previous Close
$9.38
Days Range
$9.05 - $9.42
52 week range
$6.02 - $13.14
Volume
307,548
Avg. Volume (30 days)
734,219
Market Cap
$644.83M
Dividend Yield
-
P/E
(2.72)
Shares Outstanding
70,704,890
FINANCIAL STATEMENTS FOR ZYMEWORKS BC INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ZYMEWORKS BC INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Galbraith Kenneth | Chair & CEO | Jan 08, 2024 | Sale | $11.22 | 5,706 | 63,996 | 23,762 | Jan 08, 2024, 06:23 PM |
| Galbraith Kenneth | Chair & CEO | Jan 05, 2024 | Sale | $10.65 | 18,198 | 193,849 | 29,468 | Jan 08, 2024, 06:23 PM |
| Astle Christopher | SVP & Chief Financial Officer | Jan 08, 2024 | Sale | $11.22 | 1,431 | 16,050 | 6,503 | Jan 08, 2024, 06:14 PM |
| Astle Christopher | SVP & Chief Financial Officer | Jan 05, 2024 | Sale | $10.65 | 4,563 | 48,606 | 7,934 | Jan 08, 2024, 06:14 PM |
| Moore Paul Andrew | Chief Scientific Officer | Jan 05, 2024 | Sale | $10.65 | 7,460 | 79,465 | 9,706 | Jan 08, 2024, 06:01 PM |
| Moore Paul Andrew | Chief Scientific Officer | Jan 08, 2024 | Sale | $11.22 | 2,339 | 26,233 | 7,367 | Jan 08, 2024, 06:01 PM |
| Astle Christopher | SVP & Chief Financial Officer | Dec 11, 2023 | Sale | $9.13 | 886 | 8,089 | 1,997 | Dec 11, 2023, 08:00 PM |
| EcoR1 Capital, LLC | 10% Owner | Jun 16, 2023 | Buy | $8.12 | 3,350,000 | 27,202,000 | 13,437,473 | Jun 21, 2023, 04:04 PM |
| EcoR1 Capital, LLC | 10% Owner | Mar 28, 2023 | Buy | $8.00 | 200,000 | 1,600,000 | 10,087,473 | Mar 30, 2023, 05:47 PM |
| Klompas Neil A | President & COO | Mar 10, 2023 | Sale | $7.83 | 2,977 | 23,298 | 17,032 | Mar 14, 2023, 05:00 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 19, 2023 | Buy | $9.49 | 144,100 | 1,367,639 | 9,724,073 | Jan 23, 2023, 06:00 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 20, 2023 | Buy | $9.88 | 163,400 | 1,615,095 | 9,887,473 | Jan 23, 2023, 06:00 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 18, 2023 | Buy | $10.00 | 203,000 | 2,029,046 | 9,579,973 | Jan 18, 2023, 06:27 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 17, 2023 | Buy | $9.80 | 440,000 | 4,313,848 | 9,376,973 | Jan 18, 2023, 06:27 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 13, 2023 | Buy | $9.81 | 342,100 | 3,354,633 | 8,936,973 | Jan 18, 2023, 06:27 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 11, 2023 | Buy | $7.87 | 106,300 | 836,911 | 8,594,873 | Jan 12, 2023, 04:47 PM |
| EcoR1 Capital, LLC | 10% Owner | Jan 10, 2023 | Buy | $7.65 | 920,000 | 7,037,172 | 8,488,573 | Jan 12, 2023, 04:47 PM |
| Astle Christopher | SVP & Chief Financial Officer | Dec 12, 2022 | Sale | $6.01 | 887 | 5,331 | 1,333 | Dec 23, 2022, 08:00 PM |
| Josephson Neil | Chief Medical Officer | Nov 10, 2022 | Sale | $8.10 | 2,475 | 20,045 | 14,449 | Dec 23, 2022, 08:00 PM |
| Astle Christopher | SVP & Chief Financial Officer | Dec 12, 2022 | Sale | $6.01 | 887 | 5,331 | 1,333 | Dec 14, 2022, 08:00 PM |
| Josephson Neil | Chief Medical Officer | Nov 10, 2022 | Sale | $8.10 | 2,475 | 20,045 | 14,449 | Nov 14, 2022, 09:41 PM |
| Redmile Group, LLC | 10% Owner | Oct 13, 2022 | Buy | $5.03 | 30,481 | 153,435 | 6,075,918 | Oct 18, 2022, 06:07 AM |
| Redmile Group, LLC | 10% Owner | Oct 13, 2022 | Option Exercise | $5.03 | 30,481 | 153,435 | 6,075,918 | Oct 17, 2022, 09:48 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Galbraith Kenneth | Chair & CEO | 01/08/2024 | 63,996 |
| Galbraith Kenneth | Chair & CEO | 01/05/2024 | 193,849 |
| Astle Christopher | SVP & Chief Financial Officer | 01/08/2024 | 16,050 |
| Astle Christopher | SVP & Chief Financial Officer | 01/05/2024 | 48,606 |
| Moore Paul Andrew | Chief Scientific Officer | 01/05/2024 | 79,465 |
| Moore Paul Andrew | Chief Scientific Officer | 01/08/2024 | 26,233 |
| Astle Christopher | SVP & Chief Financial Officer | 12/11/2023 | 8,089 |
| EcoR1 Capital, LLC | 10% Owner | 06/16/2023 | 27,202,000 |
| EcoR1 Capital, LLC | 10% Owner | 03/28/2023 | 1,600,000 |
| Klompas Neil A | President & COO | 03/10/2023 | 23,298 |
| EcoR1 Capital, LLC | 10% Owner | 01/19/2023 | 1,367,639 |
| EcoR1 Capital, LLC | 10% Owner | 01/20/2023 | 1,615,095 |
| EcoR1 Capital, LLC | 10% Owner | 01/18/2023 | 2,029,046 |
| EcoR1 Capital, LLC | 10% Owner | 01/17/2023 | 4,313,848 |
| EcoR1 Capital, LLC | 10% Owner | 01/13/2023 | 3,354,633 |
| EcoR1 Capital, LLC | 10% Owner | 01/11/2023 | 836,911 |
| EcoR1 Capital, LLC | 10% Owner | 01/10/2023 | 7,037,172 |
| Astle Christopher | SVP & Chief Financial Officer | 12/12/2022 | 5,331 |
| Josephson Neil | Chief Medical Officer | 11/10/2022 | 20,045 |
| Astle Christopher | SVP & Chief Financial Officer | 12/12/2022 | 5,331 |
| Josephson Neil | Chief Medical Officer | 11/10/2022 | 20,045 |
| Redmile Group, LLC | 10% Owner | 10/13/2022 | 153,435 |
| Redmile Group, LLC | 10% Owner | 10/13/2022 | 153,435 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ZYMEWORKS BC INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 4,095,729 | 0.001% | 4.39% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 1,601,000 | 0.08% | -8.83% | Event Driven, Value |
| AQR CAPITAL MANAGEMENT LLC | 489,502 | 0.00877% | -28.66% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 668,984 | 0.00065% | 4.58% | Other |
| PLATINUM INVESTMENT MANAGEMENT LTD | 418,376 | 0.18% | 2.08% | Growth At A Reasonable Price, Value |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 54,457 | 0.04% | -60.05% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 115,600 | 0.00191% | 686.39% | Other |
| ALPS ADVISORS INC | 31,440 | 0.00234% | New | Other |
| D. E. SHAW & CO., INC. | 27,113 | 0.00024% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR ZYMEWORKS BC INC
STOCK BUYBACKS FOR ZYMEWORKS BC INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
7.68%
1Q
09/30/2023
8.04%
2Q
06/30/2023
13.32%
3Q
03/31/2023
14.24%
4Q
12/31/2022
14.27%
5Q
09/30/2022
14.70%
6Q
06/30/2022
14.91%
7Q
03/31/2022
24.23%
8Q
12/31/2021
46.21%
9Q
09/30/2021
45.96%
10Q
06/30/2021
48.28%
11Q
03/31/2021
48.44%
12Q
12/31/2020
49.09%
13Q
09/30/2020
49.79%
14Q
06/30/2020
50.13%
15Q
03/31/2020
56.61%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ZYMEWORKS BC INC
LOADING...